GOPA

GOPA's vision is a world where the Alliance supports and inspires advocacy for people living with and affected by obesity locally and globally - the strong and unified voices of GOPA are recognized as knowledgeable and impactful stakeholders in the understanding of obesity... As a unified voice, GOPA is proud to join together obesity patient organizations from around the world to create change in obesity on a global level... GOPA serves as an independent, informal coalition of patient groups; it is not a legal entity and as such does not directly receive or distribute any funds. Novo Nordisk has supported GOPA by providing funding for an independent secretariat to support the day-to-day running of GOPA. Industry partners have no influence on the choice, content or execution of any activities. All GOPA activities and materials are developed and created solely by GOPA as a patient led organisation, and outside influence on content and editorial is strictly prohibited.

Also known as: Global Obesity Patient Alliance, GOPA.org

Primary location: Tampa United States